YK-11 or Ostarine: what is the difference
YK-11 or Ostarine: steroidal and nonsteroidal structure, mechanism of action, level of evidence, risks and legal status. A comparative editorial review with sources.
Training
Programs, exercise technique and load planning.· 48 articles
Training
YK-11 vs Ostarine: what to choose and for whom
YK-11 vs Ostarine: to whom these substances may seem attractive, why for athletes, women and people with chronic illnesses the answer is "neither", and what legal alternatives exist.
S4 or Ostarine: what is the difference
S4 (andarine) or Ostarine: common origin, differences in pharmacology, preclinical and clinical data, reports of vision disturbances, risks and status in sport.
S4 vs Ostarine: what to choose and for whom
S4 vs Ostarine: how to evaluate the choice between two unregistered SARMs, which groups of people are most at risk, what is worth checking in lab tests and what legal routes to results exist.
Cardarine or Clenbuterol: what is the difference
Cardarine (GW501516) or Clenbuterol: a PPARδ agonist versus a β2-adrenergic agonist. Mechanisms, study data, toxicity, cardiovascular and oncological risks, WADA status.
Cardarine vs Clenbuterol: what to choose and for whom
Cardarine vs Clenbuterol: whether it makes sense to choose between them for weight loss or endurance, to whom they are especially dangerous, warning symptoms and evidence-based alternatives for reducing fat mass.
MK-677 or CJC-1295: what is the difference
MK-677 (ibutamoren) or CJC-1295: an oral ghrelin mimetic versus a GHRH analog with DAC. Receptors, pharmacokinetics, effect on GH and IGF-1, side effects and clinical study data.
MK-677 vs CJC-1295: what to choose and for whom
MK-677 vs CJC-1295: to whom these growth-hormone stimulators are especially risky, why healthy people do not need them, which lab tests matter and what actually supports natural GH secretion.
Ipamorelin or GHRP-2: what is the difference
Ipamorelin or GHRP-2 (pralmorelin): two peptide ghrelin mimetics. Structure, selectivity with respect to cortisol and prolactin, effect on appetite, medical use, risks and WADA status.
Ipamorelin vs GHRP-2: what to choose and for whom
Ipamorelin vs GHRP-2: whether a "choice" between secretagogue peptides makes sense, to whom they are contraindicated, why "selectivity" does not equal safety, quality problems and evidence-based alternatives.
YK-11 or Ostarine: what is the difference
YK-11 or Ostarine: steroidal and nonsteroidal structure, mechanism of action, level of evidence, risks and legal status. A comparative editorial review with sources.
YK-11 vs Ostarine: what to choose and for whom
YK-11 vs Ostarine: to whom these substances may seem attractive, why for athletes, women and people with chronic illnesses the answer is "neither", and what legal alternatives exist.